EU Investigates Ties Of India’s Lupin, Others To Generics Antitrust Acts
This article was originally published in PharmAsia News
Executive Summary
The European Union says it is investigating India's Lupin and other international drug makers for possible involvement in collusion involving generic blood-pressure drugs. According to the European Commission, the executive branch of the EU, it suspects Lupin, Teva Pharmaceutical, Krka, Mylan and Unichem Laboratories subsidiaries of participating in an effort to keep a generic off the market. The antitrust investigation is part of a wider commission probe into the operations of the pharmaceutical industry in general, including how makers of branded drugs compete with generics makers. The company at the core of this probe is Les Laboratoires Servier, maker of the Coversyl, or Aceon (perindopril) ACE Inhibitor. (Click here for more - a subscription may be required